Related Experiment Video
Updated: May 30, 2026

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
Published on: June 26, 2018
Intrathecal baclofen therapy: benefits and complications
Helena Aniansson Zdolsek1, Christine Olesch, Giuliana Antolovich
1Department of Developmental Medicine, Royal Children's Hospital, and University of Melbourne, Melbourne, Australia.
Insights
Intrathecal baclofen therapy (ITB) for children with cerebral palsy can cause complications, but most parents find the treatment beneficial for managing spasticity and dystonia.
Area of Science:
- Pediatric Neurology
- Rehabilitation Medicine
Background:
- Intrathecal baclofen therapy (ITB) has been used since 1999 at the Royal Children's Hospital, Melbourne, for managing spasticity and dystonia in children with cerebral palsy.
- Cerebral palsy (CP) affects motor function, leading to conditions like spasticity and dystonia.
Purpose of the Study:
- To evaluate the complications and side effects of ITB in pediatric CP patients.
- To assess the health and functional impact of ITB from a parent's perspective.
Main Methods:
- Retrospective review of patient records from September 1999 to August 2005.
- Parental questionnaires assessing health and functional outcomes.
Main Results:
- 18 pump insertions, 6 removals, and 4 reinsertions were performed.
- 17 complications occurred in 14 out of 18 children, primarily post-insertion.
- Despite complications and limited functional improvement, 11 of 12 parents reported ITB as beneficial.
Conclusions:
- ITB treatment in pediatric CP patients is associated with complications, often early after pump insertion.
- The majority of children experience substantial benefits from ITB, as perceived by their parents.
Background:
Spasticity and dystonia in children with cerebral palsy has been treated with intrathecal baclofen therapy (ITB) at the Royal Children's Hospital, Melbourne, Australia (RCH) since 1999.
Methods:
The records of children having received or still receiving ITB during the period September 1999 until August 2005 were studied to evaluate complications and side effects. Parents answered a questionnaire focused on the health and functional impact in the children.
Results:
There were 18 first insertions of pumps, 6 removals, and 4 reinsertions. The longest treatment was 5 years and 11 months and was still ongoing. Seventeen complications occurred in 14 out of 18 children. Despite the high complication rate and the lack of significant functional improvement, 11 out of 12 parents agreed that ITB was beneficial.
Conclusion:
ITB treatment at RCH over the years has resulted in some complications, mostly occurring shortly after pump insertion. For the majority of children there are substantial benefits.
Related Concept Videos
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Centrally Acting Muscle Relaxants: Therapeutic Uses
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...
